NCT01220401

Brief Summary

The purpose of this study is to find out what effects Exposure, Rescripting, and Relaxation Therapy (ERRT) has on nightmares and associated problems in veterans.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 13, 2010

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
3 years until next milestone

Results Posted

Study results publicly available

August 8, 2014

Completed
Last Updated

April 30, 2019

Status Verified

April 1, 2019

Enrollment Period

10 months

First QC Date

October 11, 2010

Results QC Date

March 29, 2014

Last Update Submit

April 22, 2019

Conditions

Keywords

NightmarePTSDPosttraumatic stress disorderSuicideExposure Relaxation Rescription TherapySleep

Outcome Measures

Primary Outcomes (3)

  • Number of Nights With Nightmares

    This fill-in-the-blank variable assesses the number of nights the individual experienced nightmares in the past week (range = 0 - 7 nights). Higher values indicate more nights with nightmares (worse outcome).

    pre, one week, two months

  • Clinician Administered PTSD Scale

    This semi-structured clinical interview assesses each of 17 DSM-IV-TR criteria for PTSD utilizing separate queries for frequency and severity on a 5-point scale (0 - 4). This study utilized the "FI/I2" rule, where frequency ratings of one or more and intensity ratings of two or more must be present in order for a symptom to count towards diagnosis. Total scores are comprised of the three factors (reexperiencing, avoidance, and hyperarousal), with 136 being the maximum. 0-19 = asymptomatic or few symptoms. 20-39 = mild PTSD, subthreshold. 40-59 = moderate PTSD at threshold. 60-79 = severe PTSD. 80+ = extreme PTSD.

    pre, one week, two months

  • Past Week Nightmare Frequency

    This fill-in-the-blank variable assesses the number of nightmares experienced in the past week (range = 0 - X nightmares). Higher values indicate more nightmares (worse outcome).

    pre, one week, two months

Secondary Outcomes (1)

  • Beck Depression Inventory

    Baseline, 1 week, 2 months

Study Arms (1)

ERRT-M

EXPERIMENTAL

Exposure, Relaxation, and Rescripting Therapy for military populations. 4 sessions.

Behavioral: exposure, relaxation, and rescription therapy

Interventions

veterans reporting chronic nightmares at least once per week for the past month who consent to participate will attend four consecutive weekly sessions lasting approximately two hours each. Participants will log their sleep events and associated symptoms (i.e. PTSD, depression, etc.)

ERRT-M

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Tulsa

Tulsa, Oklahoma, 74104, United States

Location

MeSH Terms

Conditions

Sleep Wake DisordersStress Disorders, Post-TraumaticSuicide

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersStress Disorders, TraumaticTrauma and Stressor Related DisordersSelf-Injurious BehaviorBehavioral SymptomsBehavior

Results Point of Contact

Title
Dr. Noelle Balliett
Organization
University of Tulsa

Study Officials

  • Noelle Balliett, MA

    The University of Tulsa

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

October 11, 2010

First Posted

October 13, 2010

Study Start

October 1, 2010

Primary Completion

August 1, 2011

Study Completion

August 1, 2011

Last Updated

April 30, 2019

Results First Posted

August 8, 2014

Record last verified: 2019-04

Locations